Reps. Van Duyne and Wasserman Schultz introduce the Breast Cancer Research Stamp Reauthorization Act

Washington, D.C. - U.S. Representatives Beth Van Duyne (R-TX-24) and Debbie Wasserman Schultz (D-FL-25) introduce H.R. 8358 the Breast Cancer Research Stamp Reauthorization Act of 2026. This legislation extends the U.S. Postal Service's authority to issue the Breast Cancer Research semipostal stamp for an additional 10 years, ensuring continued voluntary funding for breast cancer research. A companion bill has been introduced in the U.S. Senate by Senator Ashley Moody (R-FL) and Senator Jacky Rosen (D-NV).

The Breast Cancer Research stamp has raised millions of dollars for lifesaving research while giving Americans a simple way to support the fight against breast cancer. With the current authorization set to expire in 2027, this bill ensures the program can continue supporting innovative research and advancing progress against one of the most common cancers affecting women in the United States.

"The Breast Cancer Research stamp program proves that small actions can make a big difference, raising nearly $100 million for lifesaving research over the past three decades," said Congresswoman Beth Van Duyne. "I am glad to lead this bipartisan, bicameral effort to extend the program for another decade to give Americans an easy, voluntary way to support the fight against a disease that impacts 1 in 8 women."

"I know what it's like to hear the dreaded words: 'you have breast cancer.' As a survivor, this fight is personal," said Congresswoman Debbie Wasserman Schultz. "That's why I'm proud to lead this bipartisan effort to reauthorize the Breast Cancer Research stamp program, which raised nearly $100 million for lifesaving studies at the Defense Department and NIH. Every stamp purchase is a commitment to beat this deadly disease."

Reps. Van Duyne and Wasserman Schultz were joined by Reps. Bacon (R-NE-2), Cohen (D-TN-9), Dingell (D-MI-6), Fitzpatrick (R-PA-1), Garamendi (D-CA-8), and Matsui (D-CA-7) in introducing the bill.

The bill was also supported by the Alliance for Women's Health and Prevention, American College of Obstetricians and Gynecologists, American College of Surgeons, American Medical Women's Association, American Society of Breast Surgeons, American Society of Plastic Surgeons, American Society for Radiation Oncology, Breastcancer.org, Cancer Nation, CancerCare, Check for a Lump, DenseBreast-info, Inc., FORCE: Facing Our Risk of Cancer Empowered, HealthyWomen, Living Beyond, Breast Cancer, Livestrong, Lobular Breast Cancer Alliance Inc., Male Breast Cancer Global Alliance, Men Supporting Women With Cancer, METAvivor Research and Support, NAACP, National Association of Nurse Practitioners in Women's Health, National Black Nurses Association, National Cancer Registrars Association, National Consortium of Breast Centers, Nueva Vida, Oncology Nursing Society, Prevent Cancer Foundation, SHARE Cancer Support, Society of Breast Imaging, Susan G. Komen, The Brem Foundation to Defeat Breast Cancer, Tigerlily Foundation, Triage Cancer, Unite for HER, and Young Survival Coalition. Click here to read their letter of support.

"Susan G. Komen applauds the leadership of Senators Rosen and Moody and Congresswomen Van Duyne and Wasserman-Schultz in introducing legislation to reauthorize the Breast Cancer Research Stamp and urge Congress to swiftly act. This bicameral, bipartisan legislation represents a critical opportunity to sustain a proven, innovative funding mechanism that has advanced lifesaving breast cancer research," said Molly Guthrie, vice president of policy and advocacy for Susan G. Komen. "For almost three decades, the Breast Cancer Research Stamp has raised nearly $98 million for breast cancer research-research that has led to significant progress in the detection and treatment of this disease but is still estimated to take the lives of 43,000 Americans in 2026 alone. Every dollar raised through the Breast Cancer Research Stamp can help advance needed discoveries and save more lives."

"For decades, progress against breast cancer has depended on strong, sustained support for research. The Breast Cancer Research Stamp has empowered Americans to be part of that effort while helping generate critical funding for breast cancer research at the National Institutes of Health and the Department of Defense medical research programs. Reauthorizing the stamp preserves a proven tool that raises awareness of breast cancer and helps fuel scientific innovation to improve treatment options and resources for patients, survivors, and those at high risk of the disease." - Ronald J. Weigel, MD, PhD, MBA, FACS, Medical Director, Cancer Programs, American College of Surgeons

Click HERE to read bill text.

Click here to read the letter of support from ASBrS.

###